Studies on the metabolism and detectability of the designer drug β-naphyrone in rat urine using GC-MS and LC-HR-MS/MS

Drug Testing and Analysis

Volumn 5, Issue 4, 2013, Pages 259-265

  Meyer, Markus R ^a   Prosser, Denise ^a   Maurer, Hans H ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Designer drug; GC MS; Metabolism; Naphyrone

Indexed keywords

BODY FLUIDS; GAS CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLITES; PHYSIOLOGY; RATS;

CATHINONE; CLASSIFIEDS; DESIGNER DRUGS; DETECTABILITY; GAS CHROMATOGRAPHY-MASS SPECTROMETRY TECHNIQUES; GC-MS; NAPHYRONE; PYRROLIDINE RINGS; RAT URINE; URINE SAMPLE;

METABOLISM;

AMINE; BETA NAPHYRONE; CATHINONE; DESIGNER DRUG; DRUG METABOLITE; LACTAM; PYRROLIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; DRUG DEGRADATION; DRUG DETERMINATION; DRUG LEGISLATION; DRUG MARKETING; DRUG METABOLISM; DRUG URINE LEVEL; HYDROXYLATION; LIQUID CHROMATOGRAPHY; MALE; MASS FRAGMENTOGRAPHY; MASS SPECTROMETRY; NONHUMAN; OXIDATION; PRIORITY JOURNAL; RAT; URINALYSIS;

ANIMALS; CYTOCHROME P-450 ENZYME SYSTEM; DESIGNER DRUGS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; MALE; OXIDATION-REDUCTION; PENTANONES; PYRROLIDINES; RATS; RATS, WISTAR; STREET DRUGS; TANDEM MASS SPECTROMETRY;

EID: 84876796878     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.1443     Document Type: Article

References (20)

1. S.D. Brandt, H.R. Sumnall, F. Measham, J. Cole Analyses of second-generation 'legal highs' in the UK: initial findings. Drug Test. Anal. 2010, 2, 377.
2. S.D. Brandt, S. Freeman, H.R. Sumnall, F. Measham, J. Cole Analysis of NRG 'legal highs' in the UK: Identification and formation of novel cathinones. Drug Test. Anal. 2011, 3, 569.
3. P.G. De Paoli, P.D. Maskell, D.J. Pounder Naphyrone: Analytical profile of the new "legal high" substitute for mephedrone. J. Forensic Legal Med. 2011, 18, 93.
4. A. Derungs, S. Schietzel, M.R. Meyer, H.H. Maurer, S. Krahenbuhl, M.E. Liechti Sympathomimetic toxicity in a case of analytically confirmed recreational use of naphyrone (naphthylpyrovalerone). Clin. Toxicol. (Phila.) 2011, 49, 691.
5. S.D. Brandt, R.C. Wootton, P.G. De, S. Freeman The naphyrone story: The alpha or beta-naphthyl isomer? Drug Test. Anal. 2010, 2, 496.
6. J.M. Prosser, L.S. Nelson The toxicology of bath salts: A review of synthetic cathinones. J. Med. Toxicol. 2012, 8, 33.
7. L.D. Simmler, T.A. Buser, M. Donzelli, Y. Schramm, L.H. Dieu, J. Huwyler, et al. Pharmacological characterization of designer cathinones in vitro. Br. J. Pharmacol. 2012. [Epub ahead of print]
8. P.C. Meltzer, D. Butler, J.R. Deschamps, B.K. Madras 1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (pyrovalerone) analogues: A promising class of monoamine uptake inhibitors. J. Med. Chem. 2006, 49, 1420.
9. D.M. Mueller, K.M. Rentsch Generation of metabolites by an automated online metabolism method using human liver microsomes with subsequent identification by LC-MS(n), and metabolism of 11 cathinones. Anal. Bioanal. Chem. 2012, 402, 2141.
10. H.H. Maurer, K. Pfleger, A.A. Weber Mass Spectral Library of Drugs, Poisons, Pesticides, Pollutants and their Metabolites, Wiley-VCH, Weinheim, 2011.
11. H.H. Maurer, K. Pfleger, A.A. Weber Mass Spectral and GC Data of Drugs, Poisons, Pesticides, Pollutants and their Metabolites, Wiley-VCH, Weinheim, 2011.
12. M.R. Meyer, C. Vollmar, A.E. Schwaninger, H.H. Maurer New cathinone-derived designer drugs 3-bromomethcathinone and 3-fluoromethcathinone: Studies on their metabolism in rat urine and human liver microsomes using GC-MS and LC-high-resolution MS and their detectability in urine. J. Mass Spectrom. 2012, 47, 253.
13. D.K. Wissenbach, M.R. Meyer, D. Remane, A.A. Weber, H.H. Maurer Development of the first metabolite-based LC-MSn urine drug screening procedure - exemplified for antidepressants. Anal. Bioanal. Chem. 2011, 400, 79.
14. D.K. Wissenbach, M.R. Meyer, D. Remane, A.A. Philipp, A.A. Weber, H.H. Maurer Drugs of abuse screening in urine as part of a metabolite-based LC-MS(n) screening concept. Anal. Bioanal. Chem. 2011, 400, 3481.
15. A.H. Ewald, D. Ehlers, H.H. Maurer Metabolism and toxicological detection of the designer drug 4-chloro-2, 5-dimethoxyamphetamine in rat urine using gas chromatography-mass spectrometry. Anal. Bioanal. Chem. 2008, 390, 1837.
16. M.R. Meyer, F.T. Peters, H.H. Maurer Automated mass spectral deconvolution and identification system for GC-MS screening for drugs, poisons, and metabolites in urine. Clin. Chem. 2010, 56, 575.
17. F.W. McLafferty, F. Turecek Interpretation of Mass Spectra, University Science Books, Mill Valley, CA, 1993.
18. R.M. Smith Understanding Mass Spectra- A Basic Approach, Wiley, New York, 1999.
19. C. Sauer, F.T. Peters, C. Haas, M.R. Meyer, G. Fritschi, H.H. Maurer New designer drug alpha-pyrrolidinovalerophenone (PVP): Studies on its metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniques. J. Mass Spectrom. 2009, 44, 952.
20. M.R. Meyer, P. Du, F. Schuster, H.H. Maurer Studies on the metabolism of the alpha-pyrrolidinophenone designer drug methylenedioxy-pyrovalerone (MDPV) in rat urine and human liver microsomes using GC-MS and LC-high-resolution-MS and its detectability in urine by GC-MS. J. Mass Spectrom. 2010, 45, 1426.